Prime Medicine, Inc.
PRME
Rank in Stocks
#9847
Prime Medicine, Inc. operates as a biotechnology firm, dedicated to delivering... Prime Medicine, Inc. operates as a biotechnology firm, dedicated to delivering genetic therapies for various diseases by strategically employing advanced gene editing technology. Central to their platform is the "Prime Editor" system, which combines a unique Prime Editor protein—a hybrid composed of a Cas protein and a reverse transcriptase enzyme—with a specialized pegRNA molecule. This pegRNA plays a crucial role by both guiding the Prime Editor to a precise location within the genome and providing the essential template for introducing the desired modification to the target DNA sequence. The company, founded in 2019, maintains its headquarters in Cambridge, Massachusetts.
Share Price
$4.30
Last synced: 2026-11-09
Market Cap
$779.92M
Change (1 day)
-7.53%
Change (1 year)
9.69%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade Prime Medicine, Inc. (PRME)
Category
Healthcare
EPS for Prime Medicine, Inc. (PRME)
EPS as of June 2026 TTM: $-1.10
According to Prime Medicine, Inc.'s latest financial reports, its current EPS (TTM) is $-1.10. At the end of 2025 the company had an EPS of $-1.35, an increase over its 2024 EPS of $-1.65.
EPS history for Prime Medicine, Inc. from 2019 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-1.10 | -18.52% |
| 2025 | $-1.35 | -18.26% |
| 2024 | $-1.65 | -24.17% |
| 2023 | $-2.18 | 49.09% |
| 2022 | $-1.46 | -24.04% |
| 2021 | $-1.92 | 3,542.61% |
| 2020 | $-0.05 | 80.82% |
| 2019 | $-0.03 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -1,523.64% |
US
|
|
| $-7.07 | 542.73% |
US
|
|
| $-5.29 | 380.91% |
AU
|
|
| $12.88 | -1,270.92% |
BE
|
|
| $21.56 | -2,060.00% |
NL
|
Questions about Prime Medicine, Inc.'s earnings per share (EPS)
What is Prime Medicine, Inc.'s earnings per share (EPS)?
Prime Medicine, Inc.'s earnings per share (EPS) over the last twelve months is $-1.10, as of Jun 2026.
What was Prime Medicine, Inc.'s earnings per share (EPS) in 2025?
In 2025, Prime Medicine, Inc.'s earnings per share (EPS) was $-1.35, compared with $-1.65 in 2024.
How has Prime Medicine, Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Prime Medicine, Inc.'s earnings per share (EPS) was highest in 2020 ($-0.05) and lowest in 2023 ($-2.18).
How does Prime Medicine, Inc.'s earnings per share (EPS) compare with similar companies?
Prime Medicine, Inc.'s earnings per share (EPS) ($-1.10) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.